A Case of HR+ Metastatic Breast Cancer
A Case of HR+ Metastatic Breast Cancer
Case: A 62-Year-Old Woman WithDe NovoInvasive Ductal Carcinoma
- A 62-year-old woman presented to her gynecologist with a large mass in her right breast
- Breast MRI confirmed the presence of a 6-cm mass and axillary adenopathy
- Labs: ALT 95, AST 70 (elevated)
- Core needle biopsy confirmed ER+ PR (-) HER2(-) carcinoma, grade 3
- CT chest, abdomen, and pelvis showed widely scattered liver metastases
Recent Videos
Related Content
HER2-Low and -Ultralow Populations Benefit from T-DXd in HR+ mBC
November 13th 2024Article
During a Case-Based Roundtable® event, Aditya Bardia, MD, MS, FASCO, discussed data from the DESTINY-Breast04 and DESTINY-Breast06 trials for HER2-low breast cancer in the second article of a 2-part series.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020Podcast
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
